Status:
COMPLETED
The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle
Lead Sponsor:
Karbala University
Conditions:
Poor Ovarian Reserve
Platelet Derived Growth Factor
Eligibility:
FEMALE
21-49 years
Phase:
NA
Brief Summary
Objective : This study aims to evaluate the impact of ovarian PRP therapy compared to control in Poseidon females undergoing ICSI cycles. Material and Methods: A randomized controlled trial was condu...
Detailed Description
2\. Materials And Methods 2.1. Study design This study was conducted at a private fertility center in Karbala, Iraq, from Jan 2024 to Feb 2025. All participants provided written informed consent prior...
Eligibility Criteria
Inclusion
- 1 - infertile Poseidon groups 2, 3, 4 women 2- no history of chronic illness or pelvic pathology. 3- All male partners were either normozoospermic or had mild OAT delivered fresh ejaculated samples for ICSI.
Exclusion
- 1 - ovarian failure due to sex chromosome abnormalities, 2- current use of anticoagulants 3- history of bleeding disorders.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2025
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT07199868
Start Date
January 1 2024
End Date
February 28 2025
Last Update
September 30 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Collage of medicine
Baghdad, Iraq, 00964
2
Collage of medicine
Karbala, Iraq, 00964